Treatment for Candidiasis in Males

Introduction to Candidiasis Treatment

The American College of Physicians and Infectious Diseases Society of America recommends topical azole antifungals for 7-14 days as the first-line treatment for male genital candidiasis, with oral fluconazole 150 mg as a single dose serving as an effective alternative 1, 2

The Infectious Diseases Society of America suggests applying topical azole antifungals to the affected area 1-2 times daily for 7-14 days for the treatment of genital candidiasis in males 1, 2
Topical nystatin can also be used for genital candidiasis, though azoles are generally preferred 1, 2
Oral fluconazole 150 mg as a single dose is equally effective and may be preferred for convenience in treating genital candidiasis in males 1

The Centers for Disease Control and Prevention recommends applying topical azoles or polyenes to affected areas 1-2 times daily for 7-14 days for the treatment of cutaneous candidiasis 1, 2, 3
Keeping the area dry is critically important, as essential as the antifungal medication itself, in the treatment of cutaneous candidiasis 1, 2, 3

The Infectious Diseases Society of America recommends oral fluconazole 100-200 mg daily for 7-14 days as the preferred initial treatment for oropharyngeal candidiasis 1, 2, 4
Alternative topical options include clotrimazole troches 10 mg five times daily for 7-14 days or nystatin suspension 100,000 U/mL (4-6 mL four times daily) for 7-14 days for the treatment of oropharyngeal candidiasis 1, 2, 4

Systemic therapy is mandatory for esophageal candidiasis, as topical treatment is ineffective 1, 2, 4
Fluconazole 200-400 mg daily orally for 14-21 days is the preferred treatment for esophageal candidiasis 1, 2, 4

The American College of Physicians advises against treating asymptomatic colonization, as many healthy individuals carry Candida without infection, and treatment should be based on clinical symptoms, not just positive cultures 5
The Infectious Diseases Society of America recommends avoiding the use of ketoconazole or itraconazole capsules for oropharyngeal/esophageal candidiasis, as they have variable absorption and are inferior to fluconazole 1, 2

For immunocompromised patients, consider longer treatment courses (14-21 days minimum) and suppressive therapy with fluconazole may be necessary for frequent recurrences, though this increases resistance risk 1, 2, 4